Announcements Trials
Browse Landscape

Phase

Phase 1 4

Status

Completed 39Recruiting 9Terminated 8Unknown 4Active not recruiting 4Withdrawn 2Suspended 1Not yet recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 81Thoracic 79Gastrointestinal 51Head & Neck 44Genitourinary 33Gynecologic 8Tumor-Agnostic 7Sarcoma 4Other solid neoplasm 4Dermatologic 1CNS 1

Conditions

Solid Tumor 2NSCLC 1Advanced Solid Tumors 1

Interventions

Injections 17Cisplatin 15Carboplatin 15Oxaliplatin 11Gemcitabine 11pembrolizumab 8Capecitabine 8Paclitaxel 7Etoposide 7Cyclophosphamide 7toripalimab 6Pemetrexed 6Irinotecan 6Drug Therapy 6spartalizumab 5fludarabine 5camrelizumab 5Vincristine 5Radiotherapy 5Leucovorin 5tislelizumab 4apatinib 4anlotinib 4Interleukin-2 4Immune Checkpoint Inhibitors 4Granulocyte-Macrophage Colony-Stimulating Factor 4Fluorouracil 4Docetaxel 4Bevacizumab 4tremelimumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Docetaxel × Other solid neoplasm × Clear all
NCT04811118 2022-01-31

The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Unknown
27 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT04413227 2020-06-02

A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid Tumors

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 1 Unknown
30 enrolled
Other solid neoplasmThoracic

NSCLC

NCT04360317 2020-04-24

Safety of the Combination of SH003 and Docetaxel in Patients With Solid Cancer

Kyunghee University Medical Center

Phase 1 Unknown
9 enrolled
Other solid neoplasm

Solid Tumor

NCT02963168 2019-10-17

A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies

Athenex, Inc.

Phase 1 Unknown
24 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡